CWM
RMD icon

Cordatus Wealth Management’s ResMed RMD Stock Holding History

Cordatus Wealth Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-15,207
Closed -$2.36M – 134
2019
Q4 		$2.36M Sell
15,207
-119
-0.8% -$17.2K 1.17% 26
2019
Q3 		$2.07M Buy
+15,326
New +$2.01M 1.08% 28

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cordatus Wealth Management's RMD Position: Q1 2020 in Review

Cordatus Wealth Management sold out of ResMed (RMD) in Q1 2020, closing a stake of 15,207 shares — an estimated $2.36M sold.

Cordatus Wealth Management first reported a position in RMD in Q3 2019 and held it in 2 quarters. The position peaked at $2.36M in Q4 2019. 584 funds tracked by Wall St. Rank hold RMD as of Q1 2020.

  • Cordatus Wealth Management reported no remaining ResMed position as of Q1 2020 after selling out during the quarter.
  • Cordatus Wealth Management sold 15,207 ResMed shares in Q1 2020, an estimated $2.36M.
  • Cordatus Wealth Management first reported a position in ResMed in Q3 2019 and held it in 2 quarters.
  • Cordatus Wealth Management's ResMed position peaked at $2.36M in Q4 2019.
  • 584 funds tracked by Wall St. Rank held ResMed as of Q1 2020.

Based on Cordatus Wealth Management's 13F filing for Q1 2020, filed 21 Apr 2020.